Portfolio
Four programs.Two areas of science.One standard of evidence.
A deliberately focused development portfolio: licensed hair-growth programs built on Aneira Pharma science, and neurotoxin programs rooted in Object Pharma science and expertise.
Pipeline matrix
The full development-stage pipeline.
Neurotoxins — science originating from Object Pharma. Hair growth — licensed programs built on Aneira Pharma science. Every program is developed to global regulatory standards.
Scalp
- Area
- Hair Growth
- Focus area
- Pattern hair loss (androgenetic alopecia, also in women)
Road to market
Eyebrow
- Area
- Hair Growth
- Focus area
- Eyebrow density and restoration
Road to market
Bio-Comparable Program
- Area
- Neurotoxins
- Focus area
- Neurotoxin program designed around established performance standards
Road to market
Bio-Better Program
- Area
- Neurotoxins
- Focus area
- Neurotoxin program exploring differentiated characteristics
Road to market
Development status
All programs presented on this website are currently in research and development. None of the products described has been approved for commercial use by the European Medicines Agency (EMA) or any other relevant regulatory authority. References to potential indications, mechanisms of action and future applications reflect current development objectives and should not be interpreted as established evidence of efficacy, safety or clinical properties of any future product.